trending Market Intelligence /marketintelligence/en/news-insights/trending/p2dmnpub8ybibcazj88aga2 content esgSubNav
In This List

Chimerix chief strategy, commercial officer resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Chimerix chief strategy, commercial officer resigns

Chimerix Inc. said Linda Richardson resigned as chief strategy and commercial officer for personal reasons, effective June 27.

Durham, N.C.-based Chimerix develops treatments that address unmet medical needs in the U.S.